PTC Therapeutics, Inc. (PTCT)
65.30
-1.78
(-2.65%)
USD |
NASDAQ |
Mar 20, 16:00
65.25
-0.05
(-0.08%)
After-Hours: 20:00
PTC Therapeutics Research and Development Expense (Quarterly) : 133.13M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 319.50M |
| Keros Therapeutics, Inc. | 17.83M |
| Insmed, Inc. | 254.91M |
| Amicus Therapeutics, Inc. | 23.74M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |